The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...

The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and ...

A version of meloxicam designed to work faster has beat out a placebo in two late-stage studies focused on post-surgical ...

Siren Biotechnology is trying to raise $5 million via the type of crowdfunding round that’s rarely used by young drugmakers.

Vor Bio, Korro Bio, Insitro and Rallybio revealed plans to lay off chunks of their respective workforces in the latest job ...

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...

The firm, a prolific backer of drug startups, will use the cash to back companies working on therapeutics, medical devices ...

While updated study results confirmed the drug lowers a target protein, the therapy's effect on clinical outcomes was less ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

Experts say market turmoil has made it harder for buyers and sellers to agree on price, which can be an especially imposing ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.